{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:15:13Z","timestamp":1707005713092},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The RAD project","award":["Philanthropic grant"],"award-info":[{"award-number":["Philanthropic grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1245\/s10434-023-14694-8","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T19:03:03Z","timestamp":1702926183000},"page":"1440-1443","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intra-Patient Heterogeneity in Micro-satellite-stable Colorectal Metastases: Does Immunotherapy Have a Role in Colorectal Peritoneal Metastases?"],"prefix":"10.1245","volume":"31","author":[{"given":"M. B.","family":"Mirza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Marincola","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. K.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"14694_CR1","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.ctrv.2011.08.002","volume":"38","author":"M Peeters","year":"2012","unstructured":"Peeters M, Price T. Biologic therapies in the metastatic colorectal cancer treatment continuum: applying current evidence to clinical practice. Cancer Treat Rev. 2012;38:397\u2013406.","journal-title":"Cancer Treat Rev."},{"key":"14694_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.trecan.2019.12.008","volume":"6","author":"W Ceelen","year":"2020","unstructured":"Ceelen W, Ramsay RG, Narasimhan V, Heriot AG, De Wever O. Targeting the tumor microenvironment in colorectal peritoneal metastases. Trends Cancer. 2020;6:236\u201346.","journal-title":"Trends Cancer."},{"key":"14694_CR3","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","volume":"38","author":"YLB Klaver","year":"2012","unstructured":"Klaver YLB, Simkens LHJ, Lemmens VEPP, Koopman M, Teerenstra S, Bleichrodt RP, et al. Outcomes of colorectal cancer patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy. EJSO Eur J Surg Oncol. 2012;38:617\u201323.","journal-title":"EJSO Eur J Surg Oncol."},{"key":"14694_CR4","doi-asserted-by":"publisher","first-page":"20495","DOI":"10.1038\/s41598-022-23319-1","volume":"12","author":"YJ Kang","year":"2022","unstructured":"Kang YJ, O\u2019Haire S, Franchini F, IJzerman M, Zalcberg J, Macrae F, et al. A scoping review and meta-analysis on the prevalence of pan-tumor biomarkers (dMMR, MSI, high TMB) in different solid tumors. Sci Rep. 2022;12:20495.","journal-title":"Sci Rep."},{"key":"14694_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141:39\u201351.","journal-title":"Cell."},{"key":"14694_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","volume":"120","author":"NA Giraldo","year":"2019","unstructured":"Giraldo NA, Sanchez-Salas R, Peske JD, Vano Y, Becht E, Petitprez F, et al. Clinical role of the TME in solid cancer. Br J Cancer. 2019;120:45\u201353.","journal-title":"Br J Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14694-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-023-14694-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-023-14694-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T19:13:28Z","timestamp":1706987608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-023-14694-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["14694"],"URL":"https:\/\/doi.org\/10.1245\/s10434-023-14694-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare that they have no competing interests, financial or otherwise, related to the current work. All the sources of funding for the research are disclosed, and any affiliations or involvement (either competitive or amiable) in any organization or entity with a direct financial interest in the subject matter or materials discussed in the manuscript are disclosed.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The submitted work is original and provides a comprehensive analysis of the genetic and immunophenotypic landscape of CPM in mCRC patients. It has not been published elsewhere and is not under consideration by any other publication. All data, figures, and tables are original, and any similarities with existing work are cited appropriately.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publication"}},{"value":"The research was conducted after IRB approval was obtained. All procedures involving analysis of patient specimens were performed in compliance with relevant laws and institutional guidelines. The study adhered to ethical guidelines, ensuring the confidentiality and rights of the patients involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}